6885.TWO
Price:
$21.4
Market Cap:
$2.81B
BRIM Biotechnology, Inc., a clinical-stage firm, specializes in developing innovative regenerative therapies to address both ophthalmic and degenerative joint conditions. Leading its pipeline is BRM 421, a topical ophthalmic solution designed to treat moderate-to-severe dry eye syndrome, which has successfully completed a Phase 2 clinical trial in the United States. The company's development efforts also encompass BRM 423, currently in Phase 1 clinical trials for severe corneal damage; BRM 424, also in Phase 1, targeting neurotrophic keratitis; and BRM 521, which aims to alleviate and repair tissue damage caused by osteoarthritis. Founded in 2013, BRIM Biotechnology is headquartered in Taipe...[Read more]
Industry
Biotechnology
IPO Date
2022-06-24
Stock Exchange
TWO
Ticker
6885.TWO
According to BRIM Biotechnology, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -4.42. This represents a change of -48.68% compared to the average of -8.61 of the last 4 quarters.
The mean historical PE Ratio of BRIM Biotechnology, Inc. over the last ten years is -10.97. The current -4.42 PE Ratio has changed 3.93% with respect to the historical average. Over the past ten years (40 quarters), 6885.TWO's PE Ratio was at its highest in in the December 2023 quarter at -1.49. The PE Ratio was at its lowest in in the June 2023 quarter at -29.85.
Average
-10.97
Median
-11.41
Minimum
-17.33
Maximum
-4.26
Discovering the peaks and valleys of BRIM Biotechnology, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 169.41%
Maximum Annual PE Ratio = -4.26
Minimum Annual Increase = -57.02%
Minimum Annual PE Ratio = -17.33
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -8.96 | -21.95% |
| 2024 | -11.48 | 169.41% |
| 2023 | -4.26 | -57.02% |
| 2022 | -9.92 | -26.00% |
| 2021 | -13.40 | -22.67% |
| 2020 | -17.33 | 51.88% |
The current PE Ratio of BRIM Biotechnology, Inc. (6885.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-8.23
5-year avg
-9.60
10-year avg
-10.97
BRIM Biotechnology, Inc.’s PE Ratio is greater than Energenesis Biomedical CO.,LTD. (-14.79), greater than Senhwa Biosciences, Inc. (-14.62), greater than Formosa Pharmaceuticals, Inc. (-63.16), greater than TWi Biotechnology, Inc. (-18.78), greater than Medigen Biotechnology Corp. (-18.95), less than Synbio Tech Inc. (11.53), greater than UnicoCell Biomed Co., Ltd. (-42.22), greater than AnnJi (-16.29), less than Syngen Biotech Co.,Ltd. (9.71), greater than Taiwan Bio Therapeutics Co., Ltd (-11.84),
| Company | PE Ratio | Market cap |
|---|---|---|
| -14.79 | $3.05B | |
| -14.62 | $3.96B | |
| -63.16 | $3.62B | |
| -18.78 | $3.15B | |
| -18.95 | $5.02B | |
| 11.53 | $1.77B | |
| -42.22 | $5.08B | |
| -16.29 | $6.24B | |
| 9.71 | $2.37B | |
| -11.84 | $2.54B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BRIM Biotechnology, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like BRIM Biotechnology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is BRIM Biotechnology, Inc.'s PE Ratio?
How is the PE Ratio calculated for BRIM Biotechnology, Inc. (6885.TWO)?
What is the highest PE Ratio for BRIM Biotechnology, Inc. (6885.TWO)?
What is the 3-year average PE Ratio for BRIM Biotechnology, Inc. (6885.TWO)?
What is the 5-year average PE Ratio for BRIM Biotechnology, Inc. (6885.TWO)?
How does the current PE Ratio for BRIM Biotechnology, Inc. (6885.TWO) compare to its historical average?